Cargando…
Ability of Recombinant Human Catalase to Suppress Inflammation of the Murine Lung Induced by Influenza A
Influenza A virus pandemics and emerging antiviral resistance highlight the urgent need for novel generic pharmacological strategies that reduce both viral replication and inflammation of the lung. We have previously investigated the therapeutic efficacy of recombinant human catalase (rhCAT) against...
Autores principales: | Shi, Xunlong, Shi, Zhihui, Huang, Hai, Zhu, Hongguang, Zhou, Pei, Zhu, Haiyan, Ju, Dianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087580/ https://www.ncbi.nlm.nih.gov/pubmed/24385240 http://dx.doi.org/10.1007/s10753-013-9800-2 |
Ejemplares similares
-
PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice
por: Shi, Xunlong, et al.
Publicado: (2013) -
Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice
por: Shi, Xunlong, et al.
Publicado: (2013) -
Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus
por: Shi, Chenchen, et al.
Publicado: (2023) -
New metabolites from the biotransformation of ginsenoside Rb1 by Paecilomyces bainier sp.229 and activities in inducing osteogenic differentiation by Wnt/β-catenin signaling activation
por: Zhou, Wei, et al.
Publicado: (2018) -
Pharmacokinetics and Pharmacodynamics of Recombinant Human EPO-Fc Fusion Protein In Vivo
por: Shi, Xunlong, et al.
Publicado: (2013)